RM-581, a small molecule in early developpement of a new class (the aminosteroids), demonstrated its ability to block the progression or even reduce the size of cancerous tumours that are difficult to treat with conventional chemothérapy.
Le RM-581, une petite molécule en développement préclinique d'une nouvelle classe (les aminostéroïdes), a démontré une capacité à bloquer la progression ou même réduire réduire la taille des tumeurs cancéreuses difficiles à traiter avec la chimiothérapie classique.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 2705 Boul. Laurier, Québec, Qc, Canada,, Quebec City,quebec G1v 4g2,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neolyspharma.com
- Keywords
- Oncology.
- HQ
- Quebec City, Quebec
Neolys Pharma Questions
Neolys Pharma's website is http://www.neolyspharma.com
Neolys Pharma's LinkedIn profile is https://ca.linkedin.com/company/neolys-pharma
Neolys Pharma has
7 employees.
View email and phone details for 7
employees at Neolys Pharma.
Neolys Pharma's industry is
Biotechnology Research
Neolys Pharma's top competitors are
Xcube.bio,
Atek,
Eder Therapeutics,
Trienix Pharma,
Tetsunagi,
9bio Therapeutics,
Groupe Parima,
Msh Pharma,
Cryopak,
Jamp Pharma Group.
Neolys Pharma's categories are Biotechnology Research
Neolys Pharma's founding year is 2023
